BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Meridian Co. Ltd. (MRDAF) Appoints John Y.C. Myung as New President and CEO


7/15/2009 7:38:43 AM

Bookmark and Share

Meridian Co., Ltd. is pleased to announce that John Y.C. Myung becomes a president and CEO of the Company on April 15, 2009. Mr. Myung has joined the company as an International Sales Director since 2007.

Mr. Myung's has 20 years of marketing and sales experience and has held account management positions at electronic and medical device companies in Korea including LG Electronics Co., Ltd. and Medison Co., Ltd. where he served as a Director of International Sales. During his time at Medison, Myung contributed to the significant growth of sales in international markets and saw an increase of oversea sales from US $20 million to $70 million.

Mr. Myung has strong experience selling to international markets and will play an instrumental role in helping Meridian expand globally.

The Company also appointed Hyung Kyoon Kim as a new director of the Company. Mr. Kim graduated from Seoul National University with a degree in anthropology 1989. He has worked as a trading manager in Daewoo Securities for 12 years.

Hyeon Seong Myeong, the former CEO, and Soon Woong Jang resigned from the board of directors, but Mr. Myeong is still with the Company as a technical adviser.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 5 patents on its technology, and has received FDA approval and Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 2000 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan and Europe, and continues to successfully market its superior product line to a growing number of clients worldwide.

On Behalf of the Board of Directors,

John Y.C. Myung, President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company. Contact:

Contacts: Meridian Co., Ltd. Peter Holeczek Corporate Communications 604-688-2448 www.meridian.co.kr

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES